Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Nausea Treatment Guidelines

Initial Assessment and Treatment

  • The National Comprehensive Cancer Network recommends evaluating patients with nausea for specific causes, including constipation, central nervous system pathology, chemotherapy, radiation therapy, hypercalcemia, medications, and gastrointestinal disorders 1, 3
  • The National Comprehensive Cancer Network suggests checking for medication-induced nausea by reviewing current medications, especially opioids, which commonly cause nausea 4, 2
  • For patients with a prior history of opioid-induced nausea, prophylactic treatment with antiemetic agents is highly recommended by the National Comprehensive Cancer Network 5, 1
  • The National Comprehensive Cancer Network recommends beginning treatment with dopamine receptor antagonists, such as prochlorperazine 10 mg PO every 6 hours as needed, haloperidol 0.5-1 mg PO every 6-8 hours, metoclopramide 10-20 mg PO every 6 hours, or olanzapine 2.5-5 mg PO 5, 4, 1, 6

Persistent Nausea Management

  • If nausea persists despite as-needed regimen, the National Comprehensive Cancer Network recommends administering antiemetics around the clock for 1 week and then changing to as-needed dosing 1, 4
  • The National Comprehensive Cancer Network suggests considering adding medications with different mechanisms of action, such as serotonin (5-HT3) receptor antagonists (e.g., ondansetron 8 mg PO daily or twice daily, granisetron PO daily), anticholinergic agents (e.g., scopolamine transdermal patch 1 mg/3 days), antihistamines (e.g., meclizine), and corticosteroids (e.g., dexamethasone 2-8 mg PO or IV) 5, 1, 2, 7

Refractory Nausea Treatment

  • The National Comprehensive Cancer Network recommends reassessing the cause and severity of nausea and considering cannabinoids (dronabinol, nabilone) for chemotherapy-induced nausea and vomiting that is refractory to standard therapies 1, 2
  • For opioid-induced nausea, the National Comprehensive Cancer Network suggests considering opioid rotation if nausea persists after a trial of several opioids and above measures 5, 1
  • Alternative therapies such as acupuncture, hypnosis, or cognitive behavioral therapy may be considered for refractory nausea by the National Comprehensive Cancer Network 2, 7

Special Considerations

  • For gastritis or gastroesophageal reflux causing nausea, the National Comprehensive Cancer Network recommends using proton pump inhibitors and H2 receptor antagonists 3, 2
  • For gastric outlet obstruction, the National Comprehensive Cancer Network suggests considering corticosteroids, endoscopic stenting, or insertion of a decompressing G-tube 2
  • For patients with bowel obstruction due to cancer, the World Journal of Emergency Surgery recommends utilizing octreotide 6

REFERENCES

1

adult cancer pain, version 3.2019, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

2

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

3

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

4

palliative care version 1.2016. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

5

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

7

nccn clinical practice guidelines in oncology: palliative care. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009